Evaluation of the nature of camel retinal acetylcholinesterase: Inhibition by hexamethonium

Journal of Enzyme Inhibition

Volumn 12, Issue 4, 1997, Pages 303-311

  Alhomida, Abdullah S ^a   Kamal, Mohammad A ^a   Al Jafari, Abdulaziz A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acetylcholinesterase; Hexamethonium; Inhibition; Kinetics; Retina

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; HEXAMETHONIUM;

ANIMAL TISSUE; ARTICLE; CAMEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME INHIBITION; HYDROLYSIS; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RETINA;

EID: 0031459742     PISSN: 87555093     EISSN: None     Source Type: Journal    
DOI: 10.3109/14756369709035822     Document Type: Article

References (31)

1. Sastry, B.V. (1985). J. Ocul. Pharmacol., 1, 201-206.
2. Millar, T.J., Ishimoto, I., Chubb, I.W., Epstein, M.L. and Johnson, C.D. (1987). Neuroscience, 21, 725-742.
3. Jen, L.S., Tsang, D., Chau, R.M.W. and Shen, W.Z. (1990). Brain Res., 523, 156-160.
4. Rengstorff, R and Royston, M. (1976). J. Optom. Physiol. Optics, 53, 70-80.
5. Trussov, M.S. (1975) Am. J. Optom. Physiol. Optics, 52, 438-445.
6. Rubin, L.S. and Goldberg, M.N. (1957). J. Appl. Physiol., 11, 439-444.
7. Rubin, L.S., Krop, S. and Goldberg, M.N. (1957). J. Appl. Physiol., 11, 445-449.
8. Fleming, K. (1957). Arch. Exp. Path Pharmacol., 203, 328-334.
9. Alpern, M. and Jampel, R.S. (1959). Am J. Opthalmol., 47, 464-476.
10. Hutchins, J.B., Bernanke, J.M. and Jefferson, V.E. (1995). Exp. Eye Res., 60, 113-125.
11. Duhaiman, A.S. (1988). Curr. Eye. Res., 7, 871-876.
12. Bolser, D.C., DeGennaro, F.C., O'Reilly, S., Hey, J.A., Chapman, R.W. (1995). Eur. J. Pharmacol., 277, 159-164.
13. de-La-Coussaye, J.E., Eledjam, J J , Bruelle, P., Lefrant, J.Y., Bassoul, B., Peray, P.A., Desch, G. and Sassine, A. (1994). Anesthesiology, 80, 595-605.
14. Bernards, C.M. and Artru, A.A. (1993). Anesthesiology, 78, 902-910.
15. Temocin, S., Erenmemisoglu, A., Suer, C and Beydagi, H. (1993). Jpn. J. Physiol., 43, 567-570.
16. Al-Jafari, A.A. and Kamal, M.A. (1996) Biochem. Mol. Biol. Int., 39, 917-922.
17. Al-Jafari, A.A., Al-Khwyter, F., Kamal, M.A. and Alhomida, A.S. (1996). Jpn. J. Pharmacol , 72, 49-55.
18. Al-Khwyter, F., Kamal, M.A. and Al-Jafari, A.A. (1996). Toxicol. Lett., 87, 69-76.
19. Ellman, G.L., Courtney, D., Andres, V. and Featherston, R.M. (1961). Biochem. Pharmacol., 7, 88-95.
20. Kamal, M.A. and Al-Jafari, A.A. (1996). Cell. Pharm., 3, 45-48.
21. Al-Jafari, A.A. and Duhaiman, A.S. (1994). Cell Biochem. Funct., 12, 209-216.
22. Segel, I.H. (1975). Behaviour and Analysis of Rapid Equilibrium and Steadystate Enzyme Systems: Enzyme Kinetics, pp. 183-186. New York: John Wiley and Sons.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1953). J. Biol. Chem., 193, 265-275.
24. Al-Jafari, A.A. and Kamal, M.A. (1994). Cell. Biochem. Funct., 12, 29-35.
25. Al-Jafari, A.A. and Kamal, M.A. (1996). Biochem. Mol. Biol. Int., 38, 577-586.
26. Leatherbarrow, R.J. (1992). GraFit. Version 3.0: Erithacus Software Ltd., Staines, U.K.
27. Roufogalis, B.D. and Wickson, V.M. (1975). Mol. Pharmacol., 11, 352-360.
28. Eicher, J., Anselmet, A., Sussman, J.L., Massoulie, J. and Silman, I. (1994). Mol. Pharmacol., 45, 335-340.
29. Cohen, S.G., Chishti, S.B., Bell, D.A., Howard, S.I., Salih, E. and Cohen, J.B. (1991). Biochem. Biophys. Acta, 1076, 112-122.
30. Al-Jafari, A.A., Duhaiman, A.S. and Kamal, M.A. (1995). Toxicology, 96, 1-6.
31. Hallak, M. and Szinicz, L. (1988). Biochem. Pharmacol., 37, 819-825.